Don't quite understand the proposed fixed doses per year hospitals would pay to use a new antibiotic instead of pay per use. Once they hit their limit (say in Sept), do they tell all patients in the last quarter of the year "tough luck, bud, you can't get the new antibiotic that is working so well because we have already used our quota for this calendar year"?
Would such a proposal hurt IPIX in ABSSSI or help since we would be pretty much guaranteed as the antibiotic of choice for most all hospitals?
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links